Vanderbilt University Medical Center: Study Explores Possible Drug Target for Neurological Problems
November 04, 2022
November 04, 2022
NASHVILLE, Tennessee, Nov. 4 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Some major prospective drug repurposing opportunities form the backdrop to new research reported Oct. 28 in Science Advances. A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down it . . .
Some major prospective drug repurposing opportunities form the backdrop to new research reported Oct. 28 in Science Advances. A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down it . . .